These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2503922)

  • 1. Immunogenicity of Brucella abortus salt-extractable proteins.
    Tabatabai LB; Deyoe BL; Patterson JM
    Vet Microbiol; 1989 May; 20(1):49-58. PubMed ID: 2503922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variation of Brucella abortus 2308 infection in BALB/c mice induced by prior vaccination with salt-extractable periplasmic proteins from Brucella abortus 19.
    Pugh GW; Tabatabai LB
    Infect Immun; 1996 Feb; 64(2):548-56. PubMed ID: 8550206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical and biological properties of soluble protein preparations from Brucella abortus.
    Tabatabai LB; Deyoe BL
    Dev Biol Stand; 1984; 56():199-211. PubMed ID: 6436094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of serum bactericidal and splenic activity of Total-OMP- CagA combination from Brucella abortus and Helicobacter pylori in BALB/c mouse model.
    Abadi AH; Mahdavi M; Khaledi A; Esmaeili SA; Esmaeili D; Sahebkar A
    Microb Pathog; 2018 Aug; 121():100-105. PubMed ID: 29709690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of immune responses in Balb/c mice vaccinated with Brucella abortus Cu-Zn superoxide dismutase synthetic peptide vaccine.
    Tabatabai LB; Pugh GW
    Vaccine; 1994 Aug; 12(10):919-24. PubMed ID: 7526568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Over-expression of homologous antigens in a leucine auxotroph of Brucella abortus strain RB51 protects mice against a virulent B. suis challenge.
    Rajasekaran P; Surendran N; Seleem MN; Sriranganathan N; Schurig GG; Boyle SM
    Vaccine; 2011 Apr; 29(17):3106-10. PubMed ID: 21376799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization of BALB/c mice with a combination of four recombinant Brucella abortus proteins, AspC, Dps, InpB and Ndk, confers a marked protection against a virulent strain of Brucella abortus.
    Hop HT; Arayan LT; Huy TXN; Reyes AWB; Min W; Lee HJ; Park SJ; Chang HH; Kim S
    Vaccine; 2018 May; 36(21):3027-3033. PubMed ID: 29678458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteration of protective and serologic responses in BALB/c mice vaccinated with chemically modified versus nonmodified proteins of Brucella abortus 19.
    Pugh GW; Tabatabai LB
    Infect Immun; 1994 Dec; 62(12):5327-34. PubMed ID: 7960111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A repA-based ELISA for discriminating cattle vaccinated with Brucella suis 2 from those naturally infected with Brucella abortus and Brucella melitensis.
    Wang JY; Wu N; Liu WH; Ren JJ; Tang P; Qiu YH; Wang CY; Chang CD; Liu HJ
    Mol Cell Probes; 2014; 28(5-6):251-4. PubMed ID: 24941369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substantial Protective Immunity Conferred by a Combination of
    Arayan LT; Huy TXN; Reyes AWB; Hop HT; Son VH; Min W; Lee HJ; Kim S
    J Microbiol Biotechnol; 2019 Feb; 29(2):330-338. PubMed ID: 30609879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination of goats with a combination
    Leya M; Kim WK; Cho JS; Yu EC; Kim YJ; Yeo Y; Lyoo KS; Yang MS; Han SS; Lee JH; Tark D; Hur J; Kim B
    J Vet Sci; 2018 Sep; 19(5):643-652. PubMed ID: 29929362
    [No Abstract]   [Full Text] [Related]  

  • 12. Monophosphoryl lipid A-induced immune enhancement of Brucella abortus salt-extractable protein and lipopolysaccharide vaccines in BALB/c mice.
    Tabatabai LB; Pugh GW; Stevens MG; Phillips M; McDonald TJ
    Am J Vet Res; 1992 Oct; 53(10):1900-7. PubMed ID: 1456539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination of cattle with chemically modified and unmodified salt-extractable proteins from Brucella abortus.
    Confer AW; Tabatabai LB; Deyoe BL; Oltjen SL; Hall SM; Oltjen JW; Morton RJ; Fulnechek DL; Smith RE; Smith RA
    Vet Microbiol; 1987 Dec; 15(4):325-39. PubMed ID: 3125668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced efficacy of recombinant Brucella abortus RB51 vaccines against B. melitensis infection in mice.
    Vemulapalli R; Contreras A; Sanakkayala N; Sriranganathan N; Boyle SM; Schurig GG
    Vet Microbiol; 2004 Sep; 102(3-4):237-45. PubMed ID: 15327798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of natural and synthetic complexes of porin and O polysaccharide as vaccines against Brucella abortus in mice.
    Winter AJ; Rowe GE; Duncan JR; Eis MJ; Widom J; Ganem B; Morein B
    Infect Immun; 1988 Nov; 56(11):2808-17. PubMed ID: 2844673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective efficacy by various doses of a new brucellosis vaccine candidate based on Salmonella strains expressing Brucella abortus BSCP31, Omp3b and superoxide dismutase against brucellosis in murine model.
    Kim WK; Moon JY; Cho JS; Hur J
    Pathog Dis; 2017 Sep; 75(7):. PubMed ID: 28873944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective efficacy of a canine brucellosis vaccine candidate based on live attenuated Salmonella expressing recombinant Brucella BCSP31, Omp3b and SOD proteins in Beagles.
    Kim WK; Moon JY; Cho JS; Park BY; Hur J
    J Vet Med Sci; 2018 Sep; 80(9):1373-1379. PubMed ID: 30068897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation by western blotting of immune responses of cattle vaccinated with Brucella abortus strain 19 or infected experimentally or naturally with virulent Brucella abortus.
    Belzer CA; Tabatabai LB; Deyoe BL
    Vet Microbiol; 1991 Mar; 27(1):79-90. PubMed ID: 1904667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenic properties of soluble antigens or whole cells of Brucella abortus strain 45/20 associated with immunoadjuvants. II. Whole cells.
    Woodard LF; Toone NM; McLaughlin CA
    Can J Comp Med; 1980 Oct; 44(4):456-8. PubMed ID: 6778600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant.
    Al-Mariri A; Tibor A; Mertens P; De Bolle X; Michel P; Godefroid J; Walravens K; Letesson JJ
    Infect Immun; 2001 Aug; 69(8):4816-22. PubMed ID: 11447155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.